Literature DB >> 35849560

Transitions and challenges for people with Parkinson's and their family members: A qualitative study.

Joy Read1, Rachael Frost2, Kate Walters2, Remco Tuijt2, Jill Manthorpe3, Bev Maydon4, Jennifer Pigott1, Anette Schrag1, Nathan Davies2.   

Abstract

OBJECTIVE: To explore the experiences and challenges of people with Parkinson's and their family members living in the community through the lens of their transitions to better understand the phases and changes in their lives.
DESIGN: Qualitative study using semi-structured interviews and analysed using codebook thematic analysis. SETTING/PARTICIPANTS: Purposive sampling was used in primary and secondary healthcare services across Southern England in 2019 to recruit 21 people with Parkinson's (aged between 45-89 years) and 17 family members (13 spouses and 4 adult children, aged between 26-79 years).
RESULTS: Participants' descriptions were classified in three main phases of transition from a place of health towards greater dependency on others: 1) 'Being told you are a person with Parkinson's' (early), 2) 'Living with Parkinson's' (mid), and 3) 'Increasing dependency' (decline). Seven sub-themes were identified to describe the transitions within these three phases: phase 1: receiving and accepting a diagnosis; navigating reactions; phase 2: changing social interactions and maintaining sense of self; information: wanting to know but not wanting to know; finding a place within the healthcare system; and 3: changes in roles and relationships; and increasingly dependent.
CONCLUSION: This study has identified points of change and means of supporting key transitions such as diagnosis, changes in social connections, and increased use of secondary healthcare services so that comprehensive, holistic, individualised and well-timed support can be put in place to maintain well-being.

Entities:  

Mesh:

Year:  2022        PMID: 35849560      PMCID: PMC9292070          DOI: 10.1371/journal.pone.0268588

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

Parkinson’s is a progressive neurodegenerative condition more commonly occurring in people over the age of 60 with more men affected than women [1], and a large increase in prevalence and global burden has been reported [2]. Both motor and non-motor function are affected, impacting many physical, cognitive, emotional and psychosocial life domains [3, 4] consequently reducing quality of life [5]. It also significantly reduces carers’ quality of life, with physical and emotional ‘burden’ reported among carers of those with greater disability [6, 7]. The concept of a transition is used in many studies of long-term health conditions to refer to a relocation within health and social care settings or to different services [8]. It is also used metaphorically to refer to the psychological adjustments to change or anticipated changes affecting an individual encountering a new or emerging health status, or to another person closely affected such as a family carer [9]. Both definitions are applicable to the lives of those with Parkinson’s, but it is the latter that is the main concept used for the purpose of this paper. A review of the nursing literature on transitions [10] suggested that transitions occur when life’s circumstances change and require processes of adaptation and reorientation to integrate the changes into life. With a progressive condition such as Parkinson’s, there is the need for constant adaptation and adjustment to changes in physical and cognitive function and ability [11, 12], as well as a loss of identity over time [13], for both the person with Parkinson’s and those close to them, thus making the concept of transition potentially relevant. Transitions potentially include, for example, changes in employment status, increasingly complex pharmacological and non-pharmacological management, location of care, and overall ability and well-being in those with Parkinson’s. This can mean continued experiences of limitation or losses of independence, altered self-efficacy, and changes in self-concept and self-esteem [14]. The disease trajectory in Parkinson’s varies across individuals, with variation in both the symptoms that manifest and the timescale of symptom progression [15]. Symptoms of Parkinson’s are also unpredictable and can fluctuate daily, with ‘on’/’off’ periods, where medications are no longer working optimally, and debilitating symptoms are no longer controlled, affecting many areas of life [16]. It is important to understand the lived experience of people with Parkinson’s to enable those with Parkinson’s, those closest to them, and those providing their care, to better anticipate and be prepared with effective and relevant strategies for optimal management as Parkinson’s progresses. This study therefore aimed to explore the experiences of adults with Parkinson’s living at home in the community, and the family members closest to them, which was analysed through the lens of transitions.

Methods

Design

An explorative qualitative study, using semi-structured interviews with people with Parkinson’s and family members who supported them, allowing for an in-depth exploration of their lived experiences. Interviews were analysed using thematic analysis, with reporting guided by the Standards for Reporting Qualitative Research framework (COREQ) [17].

Sampling and participants

Purposive sampling was used to ensure a range of ages, genders, ethnicities, marital status, home support, location, time since diagnosis, and level of disability as guided by the Schwab & England inventory [18]. For sampling we adopted the concept of information power [19], we were interested in interviewing a range of participants according to the above criteria. We continuously reflected on the quality and richness of the data collected. Towards the end of data collection we discussed as a team the depth of information we had received and agreed that it was appropriate to stop further recruitment of participants, confident we were able to answer our study aims and objectives. Participants were recruited through hospital outpatient clinics and General Practice (GP) surgeries (January—July 2019). Exclusion criteria were: Atypical Parkinsonism, living in a care home, lacked capacity to provide informed consent to an interview, or had a life expectancy of less than six months. There were no exclusion criteria for family members other than they had to be 18 years and over.

Ethics

This study was given a favourable opinion by the London Queen’s Square Research Ethics Committee (18/LO/1470). Written informed consent was obtained from all participants.

Procedure

Recruitment of people with Parkinson’s and their family members was through NHS Parkinson’s services and primary care, with clinicians making initial approaches. Potential participants received an invitation letter, information leaflet and reply slip. Those indicating interest were screened, given the opportunity to ask questions, and an interview arranged with a member of the research team. A topic guide for both people with Parkinson’s and family members was developed, based on the study objectives and key literature [12, 20, 21] with input from members of the study’s patient and public involvement (PPI) group, and refined during a pilot and the interview process. The open-ended interview questions explored participants’ history and the challenges of having, or supporting someone with, Parkinson’s, ways of managing these and what people thought might be helpful to better self-manage their condition. This included questions, for example, “Which are the most difficult aspects of your Parkinson’s at the moment?”; “If you are finding your Parkinson’s difficult what do you do?”. Prompts and probes, including “Can you tell me more about that”, or “How do you feel about…” were used to elicit more in-depth responses, and replies were summarised throughout enabling participants to ensure their responses were understood. The full topic guide is presented in S1 File. After written informed consent had been obtained face-to-face interviews were carried out by either (anon) or (anon). The female researcher interviewers had healthcare and/or psychology backgrounds and were further trained for this study by a senior researcher experienced in qualitative methods (anon), and therefore had the skills to build rapport and facilitate honest responses, of importance as researcher and participants were not known to one another. Participants were interviewed separately, except for two couple dyads. Apart from one couple, all took place in participants’ homes. Interviews lasted up to 90 minutes (range 60–90 mins), and were audio-recorded, transcribed verbatim, de-identified, and all transcripts checked against source recording for accuracy.

Analysis

Codebook thematic analysis, was applied to identify, analyse and report themes [22, 23]. Codebook thematic analysis was chosen as this was an explorative study, it allowed for an inductive approach to analysis as a team, helping us to construct common ideas and patterns within and across participants and present these as key themes. The analysis team was multidisciplinary spanning a range of clinical and academic expertise including neurology, primary care, gerontology, nursing, social care and psychology which allowed us to discuss a variety of ideas and perspectives about the data. Transcripts were read and checked against the original audio recordings for accuracy, transcripts were then read repeatedly by (anon) and (anon) to build familiarity and an overview of the content. Five transcripts were coded by two authors and an initial coding list was developed. This coding list was discussed and agreed upon between (anon), (anon) and (anon). The code list was used to code all transcripts line-by-line using NVivo 12 by (anon) (anon) and (anon). Codes were reviewed and discussed throughout the analysis, revisiting previously coded transcripts to apply any new or check and refine codes. Although we did not originally plan (and therefore specifically ask about) the concept of transitions in interviews, from initial inductive analysis and team discussions it was identified as a conceptual framework that would organise relevant themes in a way that would have meaning from a theoretical and clinical perspective [9, 10]. Consequently, upon completion of coding, (anon), (anon) and (anon) met to discuss and develop initial ideas of themes and sub-themes. Following this all authors met on several occasions to discuss the interpretations including nuances and subtleties within the themes, and discuss sub-themes through the lens of transitions, resulting in the three main themes and seven subthemes presented below.

Findings

The final sample (see Table 1) consisted of 21 people with Parkinson’s (labelled ‘P’ in quotes), who ranged from 45 to 89 years, the majority [12] were male, living with female spouses, and had been diagnosed with Parkinson’s for between 5 months and 20 years. Among the family members (labelled ‘C’ in quotes) 13 spouses and 4 adult children took part, ranging in age between 26 and 79 years. Participants were recruited from areas across Greater London and Hertfordshire, including rural areas.
Table 1

Participants’ demographic details and Parkinson’s characteristics (n = 21).

Those with Parkinson’sn = 21
GenderMen–n12
Women–n9
AgeMean–years72
Range–years45–89
Marital statusMarried17
Widowed4
EthnicityWhite17
Indian3
Other Asian background1
Living arrangementsWith spouse14
With other family members2
Alone4
With live-in care worker1
Duration since Parkinson’s diagnosisMean–years duration8 years
Range–years duration5 mo–20 yrs
Support of specialist nurseYes16
No4
Did not know1
Family members n = 17
GenderMen–n7
Women–n10
AgeMean–years66
Range–years26–79
Relationship to person with Parkinson’sSpouse13
Daughter/Son4
EthnicityWhite15
Indian1
Pakistani1

Themes

Participants with Parkinson’s spoke of continuous changes and adaptations in response to different and progressive symptoms, from a place of health to a state of greater dependence, across three sequential, but overlapping, ‘phases’: phase 1) Being told you are a person with Parkinson’s (early), phase 2) living with Parkinson’s (mid), and phase 3) increasing dependency (decline). These three phases and the sub-themes within these phases are represented in Fig 1 below.
Fig 1

Themes and subthemes.

The thick blue arrow reflects the movement though three phases as people transition through their Parkinson’s. The smaller vertical arrows represent multiple acute episodes which fall along this trajectory and will impact someone’s transitions. The faint line represents the undulating nature of Parkinson’s.

Themes and subthemes.

The thick blue arrow reflects the movement though three phases as people transition through their Parkinson’s. The smaller vertical arrows represent multiple acute episodes which fall along this trajectory and will impact someone’s transitions. The faint line represents the undulating nature of Parkinson’s.

Being told you are a person with Parkinson’s

The first point of transition focussed on the time of diagnosis when participants were told they have a chronic neurodegenerative disease; marking a period of becoming a person with Parkinson’s. This was where presenting symptoms were managed, future implications considered, and the process of adjustment began. The sub-themes within this theme are receiving and accepting a diagnosis; and navigating reactions.

Receiving and accepting a diagnosis

Participants with a range of disease durations recalled receiving a diagnosis of Parkinson’s as both as an internal process and as externally in the world involving noticing symptoms, going to the GP and subsequent referrals to specialists: “I was under the doctor for various things. And when I started my hand shaking, my common sense told me that it was the start of something. And I did research on it with the internet. And the word ‘Parkinson’s’ kept coming up. […] So I went to my GP and he diagnosed, he diagnosed–there was a letter where he [specialist] agrees with my doctor.” (06P. Male, Diagnosed < 1 year) Family members recalled greater perceived shock in the person with Parkinson’s when the diagnosis was unexpected or sudden, for example when admitted to hospital for an unrelated matter or being told directly by a GP based on observations without investigations or specialist referral: “She took herself up the doctor’s, and he said, ‘hold your hands up’. […] he said you’ve got Parkinson’s, so that was the diagnosis. Next door here, there’s [name], he’s only 58 […] he’s just been diagnosed as well. But he had a proper test at the hospital, some sort of brain scan I believe.” (14C. Son of female diagnosed 14 years) Reassurance was gained from the chance to ask questions and undergo what were perceived as thorough investigations, and by empathetic experts: “He (doctor) was very warm. He was understanding. He had a lot of empathy with what [name] was going through. He’s seeing it every day, but to us it was like he understood totally and was able to reassure us.” (06C. Wife of male, diagnosed < 1 year) For some younger participants or those who were at an earlier stage of family life with young children, without suspicions of having Parkinson’s, reaching a diagnosis took longer, became more of a shock, and acceptance and adjustment were less straightforward: “It was sort of out of the blue, because I was initially diagnosed as having arthritis. And I was being treated for arthritis, but eventually they said I had Parkinson’s, young onset Parkinson’s. Well I thought I didn’t, because I was quite healthy enough and everything, except for some joint pains. But slowly, gradually, the condition started sinking in.” (01P. Male, Diagnosed 8 years)

Navigating reactions

There were many accounts from those across ages, genders and disease durations of concerns around telling family members, friends and employers about their diagnosis. Others’ ignorance was felt a potential risk due to being perceived as different, impaired, incompetent or unreliable: "… nervous about telling others about it for what the other people might think, because there’s generally a lot of ignorance about Parkinson’s in society.” (16P. Male, Diagnosed 3 years) Participants had chosen to tell others about their diagnosis in various ways, and being open was seen as a positive way of helping people understand Parkinson’s, particularly when symptoms began to affect normal activities: “I decided we would never tried [try] to conceal it. We decided to just be very upfront with it. And that worked, seems to have worked for us.” (12P Male, Diagnosed 3 years) However, others chose to keep their diagnosis hidden, either because of reluctance to accept the diagnosis or because of stigma: “And there is a stigma attached to the condition back home, where I come from (India). […] So nobody would like, even my family wouldn’t like to tell anybody else that I’m having this condition. So it’s better off taking me as a drunk, rather than a PD patient.” (01P male, Diagnosed 8 years) There was particular reluctance to share the diagnosis when in paid employment. Fear of being misunderstood, with Parkinson’s seen as an older person’s condition, caused worry that ability and competence could be questioned. The potential risk of losing employment brought both short- and long-term implications for sense of identity and economic security: “My workplace doesn’t know that I’m having this condition. […] as long as I am working, as long as I can work, I’ll keep on going until then, unless I really feel the need to tell them about it.” (01P. Male, Diagnosed 8 years)

Living with Parkinson’s

The next transition was ‘Living with Parkinson’s’ which included changing social interactions and maintaining sense of self, information: wanting to know but not wanting to know, and finding a place in the healthcare system.

Changing social interactions and maintaining sense of self

Despite the strategies to manage others’ reactions and to overcome growing social isolation, a gradual reduction in social activities and relationships was described, in part attributed to the impact of Parkinson’s symptoms influencing how people felt about themselves in social situations. Reduced mobility, risk of falls, regularly needing to use the toilet, and freezing where movement of a part of the body is impossible for a short time, made going out of the home more problematic. Similarly, changes in memory, mood and speech affected interactions. Over-salivating, difficulties with dexterity or swallowing, for example, meant some were concerned with social dignity leading to greater self-consciousness both for the person with Parkinson’s and those accompanying them: “It’s not easy to socialise in that situation and I’m very conscious as well. You know, when we go out, I’ve got to help her cut her food up and, yes, avoid spillages and things like that.” (10C. Husband of female, Diagnosed 2 years) Additionally, fatigue, unpredictable symptoms, and the necessity of carefully timed medication to manage fluctuation of symptoms, and ‘on’/‘off’ periods, made it both difficult to be spontaneous or to plan: “It’s very difficult to make an appointment in the morning at the moment because I know that at some point I’m likely to be shaky.” (17P Female, Diagnosed 15 years) Despite the challenges of maintaining social contact and activities, the desire to feel ‘normal’, with a sense of purpose and satisfaction, and not defined by the condition, was demonstrated though the interactive hobbies and activities still undertaken, and sometimes adapted, such as exercise classes. For some, new social networks emerged from Parkinson’s or carers’ groups, but generally pre-existing friendships helped maintain a sense of connection. For others, faith communities were important and modifications helped maintain existing connections and attachments: “I don’t socially go out as much as what I used to. Well, I get visits from people. The band, being in the [church] band, they’re a very caring band. And most recently, one Sunday morning, I was sitting here and I heard the band outside the window. The band had come to visit me.” (6P. 75 year old male, recently diagnosed)

Information: Wanting to know, but not wanting to know

Many participants, across ages, genders and duration of Parkinson’s, valued information about the condition and practicalities such as managing finances. However, views were mixed as how to best access information, whether directly from healthcare professionals as experts, or sourcing information themselves. Some felt some information provided at the time of diagnosis was deliberately restricted to protect the person with Parkinson’s or was inadequate: “I think if GPs could be more aware or if the Parkinson’s nurse or, I don’t know. I think if they could all just be aware that one might need just a little bit more help in understanding. Understanding what one can do and can’t do and what the medication will do, what the side effects could be.” (12C. wife of male, Diagnosed 3 years) In contrast, others found information from a range of sources was supportive and empowering: “Our knowledge of Parkinson’s was virtually nilch [nothing]. […]. There’s a lot of support around, lots of help and guidance, […]. So, between us all, we can make a fair fist of it.” (13P. Male, Diagnosed 6 years) Many successfully sought information themselves, through books, hospital leaflets, personal recommendations, charities, and online. The latter was often initiated and supported by extended family members, including grandchildren, which sometimes revealed a difference in desire for knowledge between family members: “Well, they’re [children and grandchildren] always looking on, on the line, on this iPad, getting things to say. But it goes on. Frighten the life out of you. Read this, read that. […] Since they knew I had Parkinson’s, they all went up like an army. One’s looking at this book, one’s reading that one, one’s…” (15P. Male, Diagnosed 10 years) Despite family members often seeking more information some acknowledged that explicit information could be upsetting to the person with Parkinson’s: “Yes, information yes, but I don’t suppose he’d want to talk about that, because it will only upset him, won’t it?” (04C. Son of male) There were not only some different desires for information between the person with Parkinson’s and their family members but the views of people with Parkinson’s also differed, particularly whether information should focus on current symptoms alone or include the future. Some took the approach of “the less I know sometimes, the less the better, I think” (11P. Female, Diagnosed 6 years), meaning support groups were avoided out of fear of being exposed to people with advanced symptoms. For others, awareness of future possibilities helped: “You need to, somebody to tell you and to explain things to you before they get bad and before they’re not–which is the things would be more helpful.” (3P. Female, Diagnosed 8 years) Participants more commonly described wanting practical and positive information to help manage day-to-day matters and to respond to arising symptoms or situations. Discussions about future long-term care or end of life decisions were not reflected in the interviews, and coping appeared to be enabled by focusing on what it was possible to control: “Other people, they don’t realise sometimes how you don’t want to hear, like, people will say, ‘oh, what will you do when it gets to this?’ […] I know you’ve got to make precautions for the future, but ….” (06C. Daughter of male, Diagnosed < 1 year)

Finding a place in the healthcare system

Symptom progression meant increased reliance on healthcare providers, at which point some participants felt that they did not fit into the healthcare system, as Parkinson’s was not always understood by the healthcare providers they interacted with. Many considered greater continuity of care and understanding of Parkinson’s were required in primary and secondary healthcare and social care: “You can go to the doctor’s on four different occasions and see four different doctors. So, we would like to think we have some sort of priority, it’s nice to know you’re going to be met by somebody you have some confidence in.” (13P Male, Diagnosed 6 years) Admission to hospital following acute episodes, or a care home for respite, occurred when symptoms became more complex, often accompanied by a marked deterioration and difficulty coping at home. When moving from home to hospital people described feeling that their Parkinson’s specific needs were not fully met: “We told this staff nurse that your regime of four times a day with tablets is no good for my mum, it’s six times a day, or in actual fact, seven. That didn’t happen at all.” (14C. Son of female, Diagnosed 14 years] Similarly, there were complaints that despite the creation of individual care plans by nursing and care staff there was limited understanding of the fluctuations of Parkinson’s symptoms by non-specialist staff working in non-specialist environments: “People don’t understand the Parkinson’s at all, especially normal wards [general medical wards]. […] You know they fill out these questionnaires and they say what you can do for yourself. And, you know, I’ve ticked like, ‘going to the bathroom, I may need help, getting dressed, I need help.’ […] the nurses will see that you’re young and you look fine, so you don’t need any help. There will be times where they’ll leave the lunch there, but sometimes you can’t cut the food up yourself.” [03P. Female, Diagnosed 8 years] With progression of symptoms participants spoke of the increasing benefit from specialist advice, including neurologists, Parkinson’s nurses, physiotherapists and speech and language therapists. The perceived variation in provision and access to specialist services was however criticised: “But the main problem is the diversity of what’s out there and putting it all together. I mean, I’ve spoken to people who’ve never had any contact with physiotherapy, who’ve never had any contact from occupational therapists. I mean, I didn’t have contact from occupational therapists until I’d been assessed for medical retirement, which was nine years in.” (05P. Male, Diagnosed 18 years)

Increasing dependency

The final transition identified was as symptoms increased and participants experienced a significant decline in functional ability. It was identified as: changes in roles and relationships and becoming increasingly dependent.

Changes in roles and relationships

As symptoms increased participants spoke about reduced independence, subsequent role changes and increasing reliance on others for practical support, facilitation of social activities and assistance with health and care, with co-resident spouses and family members invariably taking on more responsibility. Transition within roles and renegotiation started with supervising, monitoring and supporting activities: “And she watches me while I’m getting out of the bath and getting into the bath, to make sure that I don’t fall down.” (06P. Male, Diagnosed < 1 year) Renegotiation also took place through a process of sharing activities, where the person with Parkinson’s continued to contribute in ways that were still possible alongside existing support: “If she was on her own, she’d struggle to cook the sort of meal that she would like […] So now she sits out there on a stool and says, ‘Right you set that timer for that time and this timer for that time and this and that.’” (07C. Husband of 74 year old female, diagnosed 8 years) However, over time, physical and cognitive decline meant tasks were relinquished, such as managing medications or finances: “I just do the housework or sort out the house, talk to the insurance assessor, talk to these people, those people, or make his appointments and remind him of the appointments. […] The total burden of running the house is on me.” (18C. Wife of male, Diagnosed 5 years) As attention increasingly focussed on the needs of the person with Parkinson’s, spouses often surrendered their own needs to accommodate reduced ability or to capitalise on good periods. They also became conscious of the transition from ‘spouse’ to ‘carer’, exacerbated by symptoms such as nocturia and sleep disturbance often leading to sleeping in separate rooms, resulting in loss of intimacy: “I just do feel like ‘the carer’ […]. Well, we’re not really physically intimate now, I think. He probably just sees me more as his carer.” (05C. Wife of male, Diagnosed 18 years) Although co-resident family members such as spouses provided substantial care and support, there were also instances where role transitions occurred to provide further support from non-resident family members: “My granddaughter comes in once a fortnight and cleans the house from top to bottom for me.” (04P. 71 year old male)

Increasingly dependent

Declining abilities gradually limited independence, with activities and routine tasks taking longer and requiring careful use of energy: “For a normal person, they have their energy and use it everywhere. With Parkinson’s, I use my energy wisely. I think to myself, what’s more important for me to do today. And I’ll put my energies there.” (03P. Female, Diagnosed 8 years) Several participants spoke knowledgably and insightfully about the debilitating symptoms leading to their dependence. They described increasing unpredictability of symptoms and ‘on’/ ‘off’ periods, when medications became less effective and resulted in tiredness, slowness and impossibility of doing things and therefore increased reliance on others: “I run out of dopamine. And once you run out of dopamine, the whole thing goes haywire. It’s very difficult to do anything then. […] So from 3 o’clock onwards, we’re on a downward slope to bedtime which is at 10 or 11 o’clock at night.” (12P male, Diagnosed 3 years) Although many changes took place over time, a diagnosis of dementia or discharge from hospital could highlight the extent of increasing difficulty and decline. At such times increased recognition of the need for additional support often triggered the involvement of services such as home care, and members of the multi-disciplinary team: “It’s progressively got more challenging with her deteriorating condition, which is now Parkinson’s dementia as well […] that’s when I think it really hit home because she was, I think, a bit in denial up until then. And then shortly after that, we were seen, or she was seen by a mental health nurse, a dementia nurse.” (10C. Husband to female, Diagnosed 2 years) Although increasingly less able and dependent on family members and external support agencies participants described thinking optimistically, not worrying about the unknown, gratitude for the past, acknowledging positive aspects of life, taking one day at a time, and making the most of the good days as ways of coping with worsening symptoms: “I’ve been very lucky. I had a lovely wife, I’ve got lovely children. I’ve got lovely friends. What more can you want? I’ve got a lovely flat.” (8P. Male Diagnosed 18 months)

Discussion

We identified three key points of transition, ‘being told you are a person with Parkinson’s’ (early), ‘Living with Parkinson’s’ (mid) and ‘Increasing dependency’ (decline). The data suggest that transitions were also mirrored among family members who both witnessed transitions in their relative with Parkinson’s and experienced their own changes of identity. Previous work has considered the transitions in the later stages of Parkinson’s [24] and those experienced by couples in the context of support [25]. This current paper broadens the view of transitions with each theme as a point of transition across the evolving course of Parkinson’s and to all aspects of living with the condition. Parkinson’s affects all areas of daily life, requiring adaptation in internal and external life domains which have to be reframed over time [26] reflecting the ongoing transitions described in our findings and earlier work [27]. The concept provides a framework for the multi-dimensional, multi-layered processes of transition currently describing other chronic conditions [28]; providing a holistic understanding of Parkinson’s. Whilst some of the challenges of having Parkinson’s have been reported elsewhere [12, 29–31] to our knowledge this is the first study to distinguish these various transitions in Parkinson’s in this way.

Being told you are a person with Parkinson’s (early)

The first point of transition was identified as when participants were told they have a chronic neurodegenerative disease, and our findings support the literature in that the diagnosis of Parkinson’s could be shocking and take time to be confirmed [31-33]. This paper further adds that the quality of diagnosis delivery was seen as important, including compassion and reassurance [31], the opportunity to ask questions [32], but importantly to also feel that investigations had been thorough. Whilst participants in this study did not generally report dissatisfaction about the way diagnosis was delivered, as found in other studies [34], participants from across a range of disease durations vividly recalled receiving their diagnosis, suggesting that the impact was still felt and resounded across the disease course, potentially informing adjustment. This is of relevance as studies suggest that how the diagnosis is delivered can have a negative long-term impact on quality of life [35] and satisfaction with care [21]. Improved pre and post-diagnostic care including clear, empathetic explanations of the diagnosis process could be of value (Box 1) and there is learning from other long-term conditions, such as dementia, where there are aspirations to ‘diagnose well’ to mitigate the impact of diagnosis delivery [36]. Participants with Parkinson’s described their psychosocial adjustment to the diagnosis as both an internal and external process, including navigating others’ reactions. Concerns around telling family, friends and employers about their diagnosis was managed by either being open, seen as a positive way of helping people understand Parkinson’s [37]; or keeping their diagnosis hidden due to either personal reluctance to accept the diagnosis, sometimes because of stigma [14, 38], or legitimate concerns about employment [39]. As supported by the literature [33, 40, 41] our findings suggest that experiences differ by age and stage of life. Peer-led approaches have been shown to improve activity and well-being [42, 43], however there can be ambivalence in attending such groups, possibly out of fear of encountering others with more advanced conditions [24]. The facilitation of meeting with others at the same age and stage, for example signposting to a young-onset, or recently diagnosed Parkinson’s support group, for example, the First Steps programme [42], could be of value in managing this first transition as identified in this study (Box 1).

Living with Parkinson’s (mid phase)

The ‘mid’ phase of ‘Living with Parkinson’s’ was when symptoms increasingly and to varying degrees affected mobility, memory, mood and speech, presenting challenges to remaining socially connected [44, 45]. The importance of social connectedness with multiple positive influences, including providing social identity and a sense of belonging, life satisfaction and well-being [12, 46] suggests the need for ongoing adaptive facilitation for social engagement given the progressive nature of Parkinson’s. Those specifically in the mid-phase may therefore benefit from support in navigating changing social roles, for example coaching to improve self-efficacy and manage changes in social roles (Box 1). Despite the constraint of declining capacity participants demonstrated the desire to preserve abilities, connections and normality. This was shown for example, by creatively adapting hobbies and contact with existing social groups, and sharing tasks with spouses rather than relinquishing tasks. This desire to preserve the pre-Parkinson’s self is reflected elsewhere [30, 47, 48]. Studies have also shown the importance of maintaining personal resources, function and mental health [49] and have discussed the value of support to preserve health and independence rather than focus on disability and dependence [50]. This study adds to the knowledge by showing that such an asset model to promote individual self-esteem and coping abilities [51] and preserve strengths, existing support networks and meaningful activities [12] could be further applied by health and care practitioners. This could be considered through the application of holistic interventions and social prescribing to promote well-being alongside ‘reactive’ responses to functional ‘deficits’ at the mid-phase transitions identified here (Box 1). In addition to preserving existing assets health professionals could also support individuals to recognise their needs, make informed choices, and prepare for the incorporation of future changes that will be increasingly demanded by Parkinson’s (Box 1) as suggested for managing transitions in other chronic conditions [52]. Similarly, supporting those with Parkinson’s to preserve a positive mindset and determination may be helpful as this has been shown to contribute to positive adjustment in Parkinson’s [37]. Information was important in navigating times of transition for both those with Parkinson’s and family members, particularly practical and positive information to help control and cope with current daily life [11, 12, 41]. Views however varied on the scope and depth of content and timing of delivery, supporting, the need for information to be bespoke [11, 26], not least given the heterogeneity of Parkinson‘s. Findings extend this knowledge by suggesting that the management of information needs careful discussion especially for family members who may feel the need to search for information to prepare for the future, whilst wishing to protect the person with Parkinson’s. Therefore, finding ways of facilitating more collaborative approaches between family members during the transition towards increasing dependency may be indicated, particularly in preparation for discussions about long-term future and end of life care [53] (Box 1). Symptom progression meant increased reliance on healthcare providers, however participants did not always ‘find their place’ in the healthcare system as Parkinson’s was not always understood by the non-specialist healthcare providers they interacted with, most notably for symptoms requiring hospital admission [54, 55]. Participants spoke of the increasing benefit from specialist advice as their symptoms deteriorated or became more complex [26, 27, 29] which has implications for workforce planning.

Increasing dependency (decline)

In this phase, significant increases in debilitating symptoms led to substantial reliance on others, especially co-resident spouses and family members, as reflected in a Carers UK report [56]. Transition to dependency included renegotiation of roles, with spouses often surrendering their own needs to accommodate their partners’ reduced ability or to capitalise on good periods, eventually changing from ‘spouse’ to ‘carer’ [25]; with subsequent strain as reflected elsewhere [6, 7, 29, 57]. These findings support the need for ongoing support for family carers who provide physical, emotional and social care in the home to those with advancing Parkinson’s (Box 1). This is highly relevant for times marking significant deterioration, for example a diagnosis of dementia or admission and discharge from hospital resulting in increased commitments from spouses or other family carers. Advancing symptoms, declining abilities and significant losses increasingly limited independence and affected the entirety of everyday life [27], impacting quality of life and life satisfaction of those with Parkinson’s [5, 58]. Despite declining ability participants spoke with insight and knowledge about their management of troublesome symptoms, for example fatigue, and also about medications and their effectiveness, especially in relation to unpredictable symptoms and ‘on’/‘off’ periods, also described in previous work [59]. In the later stages of Parkinson’s such a sense of autonomy and self-efficacy have been shown to be associated with life satisfaction [60]. Despite increasing dependency and isolation, both those with Parkinson’s and family members described coping strategies such as focusing on the present by taking one day at a time and making the most of the good days, feeling gratitude for the past, and acknowledging positive aspects of life.

Strengths and weaknesses

Our sample included perspectives from people with Parkinson’s and family members, who were socially diverse, recruited from inner city, suburban and rural settings. A breadth of Parkinson’s duration was represented and having more men than women is consistent with the overrepresentation of men diagnosed with Parkinson’s [1]. The study team spanned a range of clinical and academic expertise including neurology, primary care, gerontology, nursing, social care, psychology and a person with lived experience of Parkinson’s, which aided interpretation of findings and the consideration of multiple perspectives and ideas. The analysis would have benefited from inclusion of a current family carer, although one member of the research team had previously been a carer of someone with Parkinson’s. However, ethnic diversity in the sample is limited, despite efforts to recruit from services with higher prevalence of ethnic minority groups. Single people living alone were also under-represented and may have different experiences to those living with others. When considering the transferability of findings, despite international studies describing similar Parkinson’s symptoms and impacts [31, 61, 62], it is important to acknowledge that health services have regional and international variations [63] potentially changing the experiences of those with Parkinson’s.

Clinical implications

As described throughout the discussion, a range of potential clinical implications have been identified at each transition point and these are presented in Box 1.

Future research

Longitudinal exploration of the experiences of those with Parkinson’s and carers would be of value to understand transitions over a prolonged period of time, for example using case study methods. Further detailed exploration of each phase of transition for both those with Parkinson’s and the carer would be of value, for example examining stages of grief associated with managing each phase. It is important to explore which interventions and strategies over time are successful at addressing the challenges within the transitions identified here. For example, whether the reluctance to read about later stages of the condition affects care planning, particularly for those who may develop cognitive impairment, or is helpful in reducing anxiety and improving quality of life.

Conclusion

Those with Parkinson’s, and those closest to them, adapt their internal and external life domains over the trajectory of the condition from diagnosis through to decline and increasing dependence. This understanding is important to healthcare professionals, particularly non-specialists, so as to be aware of the individual’s changing needs and to support the necessary adaptations at key transitions such as diagnosis, changes in social connections, and increased use of expertise so that timely, comprehensive, holistic and individualised support can be put in place to maintain well-being. (PDF) Click here for additional data file. (DOCX) Click here for additional data file. 12 Jan 2022
PONE-D-21-37562
Transitions and challenges for people with Parkinson’s and their family members: A qualitative study
PLOS ONE Dear Dr. Davies, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.
Both reviewers have a number of positive comments regarding the potential of your manuscript of making a contribution to the literature but also highlight a number of issues with your method of analysis in terms of wanting some more details on the steps undertaken. I also agree with Reviewer #1 to include the interview guide and to also submit the COREQ with a revised manuscript. Please submit your revised manuscript by Feb 26 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sander L. Hitzig Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2.  Please include additional information regarding the interview guide used in the study and ensure that you have provided sufficient details that others could replicate the analyses. Please also include a copy as Supporting Information. 3. Thank you for stating the following in your Competing Interests section: (NO authors have competing interests) Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present a qualitative project involving people with Parkinson’s and caregivers and identifying themes relating to transitions over the course of PD. The themes are very resonant with my clinical experiences in a specialty Parkinson clinic and the discussions that I have with my patients and families about changing experiences over time. This will be an important contribution to the literature, especially for clinicians who may have less experience with this on a daily basis. The explanation of what the authors mean by “transition” in this context is important and it is good that they included it and distinguished it from the more common use of the word to mean changes in location of care. Justifications should be provided for the selection of this qualitative analysis approach. The semi-structured interview should be included as supplemental materials. Authors should provide one of the checklists for qualitative research reporting, such as COREQ. In the analysis section of the methods, it is unclear how many individuals performed the initial coding frame. Was this a single individual, who then discussed the proposed frame with the team? Or was there dual coding? Also, “read a proportion of the transcripts” is very passive. Was the team actively involved in refining the coding frame and identifying themes and subthemes? Were themes and subthemes revised iteratively over time? When the final frame/codebook was determined, were the original transcripts re-reviewed using the new codebook? It says the frame was applied to remaining interviews but it is important to re-review the initially assessed transcripts once the final theme is determined, for differences that might occur because of changes in the codebook. Discussion of results with a representative with lived experience of Parkinson is a strength. Ideally this would be with a person with PD and a caregiver, since both groups were represented in the study. I could not find a legend for Figure 1 and while I like the figure overall, it would benefit from some explanatory text. For example, I understand the trajectory because it is something that I often draw in clinic, but right now the declining line superimposed on the figure is somewhat confusing and distracting and it is possible that the non-specialist reader will not understand it without explanation. Also, the current formatting of the figure is somewhat confusing (at least how it appears in the PDF for review). The line with the acute on chronic declines is on the top, interrupting a bunch of the text, while the arrows explaining the sudden dips are at the bottom. Even as a specialist, this took me a little while to figure out (e.g., that the top line and the bottom arrows were related). I suggest putting the trajectory on its own – still in the figure, but not superimposed on the text. In addition to adjusting the layout of the figure (or how it is seen in the review PDF), a text legend will help explain what the figure is showing, particularly to those who do not routinely draw similar graphics for patients and families in the clinic. The overall figure is nice with its combination of trajectory and themes, but it could be improved with some fairly minor edits. It would be helpful to define some of the terms that are not universal. For example, “general ward staff” and “normal wards” (page 15) are not vocabulary typically used in the U.S. Can the authors briefly clarify (even parenthetically) this context for readers from different healthcare systems? The discussion does not always seem to draw specifically from the results. For example, on page 19, the authors say, “The impact of the way in which a diagnosis is delivered resounded across the disease course,” but this was not clearly described in the results, nor was it a specific theme or subtheme outlined in the text or figure. The subsequent statements about diagnosing well also need references if maintained. The disconnect between the results and the discussion persists through most of the discussion. Typically the discussion section puts the new results into context, but in this manuscript there is very little discussion of how current findings are consistent with or different from what is currently published in the literature. The discussion would benefit from some rewriting, where current results are placed into context of the published literature and then the authors make suggestions regarding how clinics/clinicians can address the challenges identified in the study. The discussion also seems to ramble a bit at times. It might be helpful to create some subheadings in the discussion to help the reader understand the points the authors are trying to emphasize. Multiple quotes describe the effect of motor fluctuations in the “mid” period, but this subtheme seems to be missing from the analysis. Given that multiple quotes describe the impact of this (and presumably there are others not included in the manuscript itself), why is this not part of the subthemes relating to the middle phase? There is at least one recent paper describing many themes that overlap with what the participants in this study describe (doi:10.1212/CPJ.0000000000000921). There are also potentially relevant references not currently included, such as studies about early stages/diagnosis (e.g. https://doi.org/10.1177/1742395317694699). Limitations should include uncertain generalizability to other healthcare contexts, though the authors can also point out where current findings are similar to results reported in research performed in other international locations. Box 1 includes exact language for some subthemes but no for others. It would be clearer if the box specifically labeled each subtheme with consistent language and then presented potential strategies to help that phase/subtheme. The columns in the box should also be labeled. Presumably the first column references the subtheme and the second column represents potential strategies to help the challenges represented in the subtheme? There might also be a third column with references to support the suggested strategies, since this goes beyond what was studied (the interviews seem to focus on experiences, not helpful strategies that participants employed or received). Box 1 should also be integrated better with the discussion. Suggest removing the sentence that findings might be of relevance to other degenerative conditions. It is likely that these other conditions have key differences in phases that would not be reflected in the current study. For example, people with MS may be affected at a younger average age, people with dementia are dependent at diagnosis, and people with HD have the challenge of living within a family where others are also likely to be affected and where they are likely to have seen the impact of the disease for years (in contrast to current findings, where people avoided support groups so they did not have to see later stages). Thus, this statement is likely incorrect but also largely irrelevant to the importance of the findings to care for people with PD and their families. The future research section is underutilized. What about research looking at stages of grief involved with coping at each phase? What about caregiver experiences of the phases (despite interviewing caregivers, much of the framework of phases seems more patient-focused)? What exactly do the authors mean by “interventions”? Interventions to address challenges? The authors also seem to pre-suppose that reluctance to read about PD is a bad thing. What if it improves quality of life and lessens anxiety? In the conclusion the authors say that “the concept of transition was a meaningful way of conceptualizing the changes psychologically…” but it is unclear – meaningful to who? Meaningful to the authors? It sounds like this was a concept developed out of the transcripts. If that is correct, then the participants could not have endorsed this as meaningful. If this framework was pre-supposed, that should be made clear in the methods and the analysis. Having the semi-structured questionnaire would also help understand this. There is no data availability statement within the manuscript. In the questions, the authors state, "All relevant data are within the manuscript and its Supporting Information files." I cannot find any supporting information files available to review. While typically the transcripts themselves are not included as supplemental files as the whole of a transcript might be identfiable even if specific identifiers are redacted, qualitative work published in PLoS One has included supplemental materials like the code book with the associated quotes for each theme and subtheme (rather than just the select quotes that are in the manuscript). Currently there is no data availability that I can tell - nothing included in supplemental materials, in a data respository, or on request. Reviewer #2: This was a well-written and interesting paper which considers the challenges of and transitions between the different stages of Parkinson’s. I have a few comments, mainly regarding the description of the method and the addition of further current literature in the discussion. I have selected "partly" to question 1 because I think the description of the data analysis needs to be improved. I do not have any concerns about the results or conclusions - I just think the description of the process of analysis needs to be clearer so one can be confident it is "technically sound". Abstract As the authors indicate in the introduction, the term transition is often used to indicate a move between different services/types of treatment etc, as well as being used in the sense the authors mean here, more a transition between disease states/ways of living. I am wondering therefore if this could be made clearer in the title and/or abstract. For example the objective is currently: “To understand the transitions experienced by people with Parkinson’s and their family members living in the community.” However, this does not make it clear what is meant by transition – so could this be explained a little more? It would also be helpful in the abstract to know which subthemes belong to which themes. Introduction This is mainly clear – with just some queries about the final paragraph, covered below. Method A little more explanation and coherence is needed regarding the method. The authors say that they conducted thematic analysis using Braun & Clarke’s (2006) approach. However, Braun & Clarke have since developed and refined their method and tend now to refer to “reflexive thematic analysis” (e.g. Braun, V. & Clarke, V. (2019) Reflecting on reflexive thematic analysis, Qualitative Research in Sport, Exercise and Health, 11:4, 589-597, DOI: 10.1080/2159676X.2019.1628806). As they outline, there are actually various types of thematic analysis so it is helpful to be more specific about which one is meant. There is a helpful summary of their development of the approach here: https://www.psych.auckland.ac.nz/en/about/thematic-analysis.html and in their new book (Braun, V. & Clarke, V. (2021). Thematic Analysis: A Practical Guide. Sage.) So I think the authors need to be more explicit whether they are using the inductive approach that Braun & Clarke outline (reflexive thematic analysis) or whether they are using a more deductive approach (e.g. codebook thematic analysis or framework analysis for example). The introduction says that the “lens of transitions” (page 4) will be used to look at the “lived experience” and then later the same paragraph talks about the “framework of transitions”. It also says that “mapping Parkinson’s onto transitions” (page 4) is a new approach. How was the mapping and using of a framework/lens actually implemented in practice? At what point was the lens introduced when conducting the data analysis? What did the mapping involve? Was the “framework of transitions” taken from previous literature or constructed for the current project? There is very little about this in the method. The method states that an “inductive approach” (page 5) was used and then later that “the concept of transitions was identified and applied” – so does this mean that the concept of transitions came from the data (i.e. when doing the inductive analysis, an overarching theme of transitions was seen) or that the project was about transitions specifically and that the interview schedule and analysis was conducted specifically focusing on transitions? This needs to be a bit clearer both in the introduction and method. The process of analysis then needs more explanation with appropriate methodological references. As a more minor issue- in a couple of places the language used does not quite align with the Braun & Clarke conceptualisation of the method. For example, Braun & Clarke argue strongly against using the word “emerge” for themes (as is used here on page 4: “no new themes emerged”) and similarly are critical about the concept of saturation (Braun, V. & Clarke, V. (2021) To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales, Qualitative Research in Sport, Exercise and Health, 13:2, 201-216, DOI: 10.1080/2159676X.2019.1704846). Thus a little more is needed here (with appropriate references) to indicate how “saturation” was conceptualised and utilised. Page 11: The topic guide was developed with reference to “the study objectives and literature” – could the citations of the relevant literature be included? Pages 11-12: “The separate code lists were compared and reviewed to create an initial coding frame. The coding frame was discussed with other members of the team (anon), who read a proportion of the transcripts. The agreed coding frame was then applied to the remaining interviews”. How many transcripts were looked at first to form the initial coding frame? Results The three themes and subthemes seem coherent and informative and the thematic map (Figure 1) gives a helpful overview of the findings. A perhaps minor point, but the quotations largely seem to focus on each phase (i.e. be static), rather than talk about the transition from one phase to the next, which is the focus, I think, of the current work? Is there anything that can be done in each theme to bring the nature of the transition (from one phase to the next) more to the fore, if this indeed is part of the intended focus? Or is each theme/phase itself seen as a transition? Perhaps this could this be clearer. Discussion There is a considerable body of (arguably) similar work in Parkinson’s that I think needs some consideration in the discussion. The Soundy et al. (2014) review is already included but there are also two more recent reviews, which I think could be relevant, both as a whole and the papers cited within: Rutten S, van den Heuvel OA, de Kruif A, et al. The subjective experience of living with Parkinson’s disease: a meta-ethnography of qualitative literature. J Parkinsons Dis.2021;11(1):139–151 and Wieringa G, Dale M, Eccles FJR. Adjusting to living with Parkinson's disease; a meta-ethnography of qualitative research. Disabil Rehabil. 2021:1-20. doi: 10.1080/09638288.2021.1981467. Epub ahead of print. The Rutten et al. review is particularly relevant to the current paper as it discusses the changes over time. The following paper also perhaps has findings relevant to the current work: Vann-Ward T, Morse JM, Charmaz K. Preserving Self: Theorizing the Social and Psychological Processes of Living With Parkinson Disease. Qualitative Health Research. 2017;27(7):964-982. doi:10.1177/1049732317707494) Page 19: “Parkinson’s affects all areas of life and acceptance has to be reframed over time (20) reflecting the ongoing transitions described in our findings.” Can this sentence be explained a little more?” Acceptance is only mentioned explicitly once in the results (as far as I can see) so it is not clear at the moment how the acceptance changing over time plays out in the results of the current paper. I think either this needs making more explicit throughout the results, or the way in which acceptance changes throughout the transitions needs to be explained more here in the discussion. Page 19: “Whilst some of the challenges of having Parkinson’s have been reported elsewhere (12, 22-24) to our knowledge this is the first study to map them onto these various transitions across the Parkinson’s.” Again, linking to my comment above on the method – was the aim therefore to “map” difficulties onto the different phases of Parkinson’s? One paragraph on page 19 focuses on the diagnosis phase. Several previous papers have also similarly considered the effects of receiving a diagnosis and could be cited including: Phillips, L.J. (2006). Dropping the bomb: The experience of being diagnosed with Parkinson’s disease. Geriatric Nursing, 27, 362-369. doi: 10.1016/j.gerinurse.2006.10.012 Pinder. (1992). Coherence and incoherence: doctors’ and patients’ perspectives on the diagnosis of Parkinson’s disease. Sociology of Health and Illness, 13, 1-23. doi: 10.1111/j.14679566.1992.tb00111.x and Warren, E., Eccles, F., Travers, V., & Simpson, J. (2016). The experiences of being diagnosed with Parkinson’s disease. British Journal of Neuroscience Nursing, 12, 288-296. doi: 10.12968/bjnn.2016.12.6.288. The following review includes Parkinson’s and so also may be relevant: Anestis E, Eccles F, Fletcher I, French M, Simpson J. Giving and receiving a diagnosis of a progressive neurological condition: A scoping review of doctors' and patients' perspectives. Patient Educ Couns. 2020; 103(9):1709-1723. doi: 10.1016/j.pec.2020.03.023. Epub ahead of print. Page 19: “The impact of the way in which a diagnosis is delivered resounded across the disease course and there is learning from other long-term conditions (LTC), such as dementia, where there are aspirations to ‘diagnose well’ to mitigate the impact of diagnosis delivery.” I think there should be a citation after this statement. Finally, the following study may be a useful comparator? Bogosian, A., Morgan, M., Bishop, F. L., Day, F., & Moss-Morris, R. (2017). Adjustment modes in the trajectory of progressive multiple sclerosis: a qualitative study and conceptual model. Psychology & Health, 32(3), 343–360. https://doi-org.ezproxy.lancs.ac.uk/10.1080/08870446.2016.1268691 ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. 11 Mar 2022 We would like to thank both reviewers and the editor for their positive review of our article and comments which we believe have strengthened our article. We have listed comments below and our responses. These have been highlighted in the revised manuscript. Both reviewers have a number of positive comments regarding the potential of your manuscript of making a contribution to the literature but also highlight a number of issues with your method of analysis in terms of wanting some more details on the steps undertaken. I also agree with Reviewer #1 to include the interview guide and to also submit the COREQ with a revised manuscript. 1., Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. We trust the manuscript meets PLOS ONES style requirements 2., Please include additional information regarding the interview guide used in the study and ensure that you have provided sufficient details that others could replicate the analyses. Please also include a copy as Supporting Information. We have made additional reference to the content of the interview guide within the manuscript i.e., by including examples of questions used – See page 5, lines 130-135. We have also submitted a copy of the interview guide as Supporting Information. We have added further information to the analysis section see page 6, lines 156-170. 3., Thank you for stating the following in your Competing Interests section: (NO authors have competing interests) Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. Thank you for this, we have declared in our cover letter we have no competing interests. 4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. The data is from interviews as part of a qualitative study. We do not have permission from participants to share their transcripts and data publicly, other than extracts for the purpose of publications. All relevant excerpts of data have been made available in the paper. Reviewers' comments: ________________________________________ 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No See previous response to editors comment. ________________________________________ ________________________________________ 5. Review Comments to the Author Reviewer #1: The authors present a qualitative project involving people with Parkinson’s and caregivers and identifying themes relating to transitions over the course of PD. The themes are very resonant with my clinical experiences in a specialty Parkinson clinic and the discussions that I have with my patients and families about changing experiences over time. This will be an important contribution to the literature, especially for clinicians who may have less experience with this on a daily basis. The explanation of what the authors mean by “transition” in this context is important and it is good that they included it and distinguished it from the more common use of the word to mean changes in location of care. Justifications should be provided for the selection of this qualitative analysis approach. We have added this to page 6-7, lines 162-170. Q., Authors should provide one of the checklists for qualitative research reporting, such as COREQ., A completed copy of the COREQ checklist has been uploaded, and reference made within the text. Q., In the analysis section of the methods, it is unclear how many individuals performed the initial coding frame. Was this a single individual, who then discussed the proposed frame with the team? Or was there dual coding? Also, “read a proportion of the transcripts” is very passive. Was the team actively involved in refining the coding frame and identifying themes and subthemes? Were themes and subthemes revised iteratively over time? When the final frame/codebook was determined, were the original transcripts re-reviewed using the new codebook? It says the frame was applied to remaining interviews but it is important to re-review the initially assessed transcripts once the final theme is determined, for differences that might occur because of changes in the codebook. Thank you for this point. The analysis section has now been substantially rewritten in order to address the points raised, specifically to clarify how many people created the initial coding frame, how it evolved further and was applied. The text also now includes a greater description of the multidisciplinary authors and their familiarity with the data and role in developing the themes and subthemes. See pages 6-7, lines 156-170. Q., Discussion of results with a representative with lived experience of Parkinson is a strength. Ideally this would be with a person with PD and a caregiver, since both groups were represented in the study. Thank you for identifying the strength of our work, we agree it could have been strengthened with the inclusion of a family carer in the discussions of the findings and we have added this to the strengths and weaknesses section, page 24, lines 617-619. Q., I could not find a legend for Figure 1 and while I like the figure overall, it would benefit from some explanatory text. For example, I understand the trajectory because it is something that I often draw in clinic, but right now the declining line superimposed on the figure is somewhat confusing and distracting and it is possible that the non-specialist reader will not understand it without explanation. Also, the current formatting of the figure is somewhat confusing (at least how it appears in the PDF for review). The line with the acute on chronic declines is on the top, interrupting a bunch of the text, while the arrows explaining the sudden dips are at the bottom. Even as a specialist, this took me a little while to figure out (e.g., that the top line and the bottom arrows were related). I suggest putting the trajectory on its own – still in the figure, but not superimposed on the text. In addition to adjusting the layout of the figure (or how it is seen in the review PDF), a text legend will help explain what the figure is showing, particularly to those who do not routinely draw similar graphics for patients and families in the clinic. The overall figure is nice with its combination of trajectory and themes, but it could be improved with some fairly minor edits. Thank you for pointing this out as it appears there was a formatting error on submission. The figure has been edited as suggested with addition of titles for both axis, re-arrangement of arrows, and a description of the figure added to the text. See page 9, lines 197-199. Q., It would be helpful to define some of the terms that are not universal. For example, “general ward staff” and “normal wards” (page 15) are not vocabulary typically used in the U.S. Can the authors briefly clarify (even parenthetically) this context for readers from different healthcare systems? We have now added an explanation of what the participant statement refers to non-specialist staff in a non-specialist environment. See page 16, lines 388-390. Q., The discussion does not always seem to draw specifically from the results. For example, on page 19, the authors say, “The impact of the way in which a diagnosis is delivered resounded across the disease course,” but this was not clearly described in the results, nor was it a specific theme or subtheme outlined in the text or figure. The subsequent statements about diagnosing well also need references if maintained. The discussion has now been amended so that all the results are more clearly integrated throughout. The resonance of the diagnosis is not considered to be a specific sub-theme, instead it is part of the existing sub-theme where a diagnosis is sought, delivery is commented upon, and the impact of this as described as resonating across the disease course. We have expanded and clarified the diagnosis section and added references in the discussion, which also addresses reviewer 2’s comments. Q., The disconnect between the results and the discussion persists through most of the discussion. Typically the discussion section puts the new results into context, but in this manuscript there is very little discussion of how current findings are consistent with or different from what is currently published in the literature. The discussion would benefit from some rewriting, where current results are placed into context of the published literature and then the authors make suggestions regarding how clinics/clinicians can address the challenges identified in the study. The discussion also seems to ramble a bit at times. It might be helpful to create some subheadings in the discussion to help the reader understand the points the authors are trying to emphasize. Thank you for this important point, the discussion has been amended to better integrate the findings into the discussion and into the context of the existing literature, and link to box 1 where suggestions are made regarding how clinicians can address the identified challenges. Q., Multiple quotes describe the effect of motor fluctuations in the “mid” period, but this subtheme seems to be missing from the analysis. Given that multiple quotes describe the impact of this (and presumably there are others not included in the manuscript itself), why is this not part of the subthemes relating to the middle phase? There is at least one recent paper describing many themes that overlap with what the participants in this study describe (doi:10.1212/CPJ.0000000000000921). There are also potentially relevant references not currently included, such as studies about early stages/diagnosis (e.g. https://doi.org/10.1177/1742395317694699). For our analysis motor fluctuation was not an independent sub-theme however along with other Parkinson’s symptoms it contributed to our understanding and development of sub-themes. Q., Limitations should include uncertain generalizability to other healthcare contexts, though the authors can also point out where current findings are similar to results reported in research performed in other international locations. The strengths and weaknesses section, page 24-25, lines 623-627, now acknowledges that despite international studies reporting similar findings about Parkinson’s symptoms, health services have regional and international variations potentially changing the experiences of those with Parkinson’s. Q., Box 1 includes exact language for some subthemes but no for others. It would be clearer if the box specifically labeled each subtheme with consistent language and then presented potential strategies to help that phase/subtheme. The columns in the box should also be labeled. Presumably the first column references the subtheme and the second column represents potential strategies to help the challenges represented in the subtheme? There might also be a third column with references to support the suggested strategies, since this goes beyond what was studied (the interviews seem to focus on experiences, not helpful strategies that participants employed or received). Thank you for this observation. Box 1 now reflects the exact language of each sub-theme and the columns are now labeled. Q., Box 1 should also be integrated better with the discussion. References to box one are now included throughout the discussion. Q., Suggest removing the sentence that findings might be of relevance to other degenerative conditions. It is likely that these other conditions have key differences in phases that would not be reflected in the current study. For example, people with MS may be affected at a younger average age, people with dementia are dependent at diagnosis, and people with HD have the challenge of living within a family where others are also likely to be affected and where they are likely to have seen the impact of the disease for years (in contrast to current findings, where people avoided support groups so they did not have to see later stages). Thus, this statement is likely incorrect but also largely irrelevant to the importance of the findings to care for people with PD and their families. We agree and we have removed this statement. Q.,The future research section is underutilized. What about research looking at stages of grief involved with coping at each phase? What about caregiver experiences of the phases (despite interviewing caregivers, much of the framework of phases seems more patient-focused)? What exactly do the authors mean by “interventions”? Interventions to address challenges? The authors also seem to pre-suppose that reluctance to read about PD is a bad thing. What if it improves quality of life and lessens anxiety? The future research section has now been expanded to include the suggested areas for additional exploration. An expanded description of ‘interventions’ as a means of addressing the challenges is now included. See page 25, lines 634-642. Q., In the conclusion the authors say that “the concept of transition was a meaningful way of conceptualizing the changes psychologically…” but it is unclear – meaningful to who? Meaningful to the authors? It sounds like this was a concept developed out of the transcripts. If that is correct, then the participants could not have endorsed this as meaningful. If this framework was pre-supposed, that should be made clear in the methods and the analysis. Having the semi-structured questionnaire would also help understand this. The concept of transitions was developed after reading through the transcripts not prior to data collection. We have removed this statement from the conclusion and elsewhere. Q., There is no data availability statement within the manuscript. In the questions, the authors state, "All relevant data are within the manuscript and its Supporting Information files." I cannot find any supporting information files available to review. While typically the transcripts themselves are not included as supplemental files as the whole of a transcript might be identfiable even if specific identifiers are redacted, qualitative work published in PLoS One has included supplemental materials like the code book with the associated quotes for each theme and subtheme (rather than just the select quotes that are in the manuscript). Currently there is no data availability that I can tell - nothing included in supplemental materials, in a data respository, or on request. We have added a data sharing statement in response to the editor’s comment. Q., Reviewer #2: This was a well-written and interesting paper which considers the challenges of and transitions between the different stages of Parkinson’s. I have a few comments, mainly regarding the description of the method and the addition of further current literature in the discussion. I have selected "partly" to question 1 because I think the description of the data analysis needs to be improved. I do not have any concerns about the results or conclusions - I just think the description of the process of analysis needs to be clearer so one can be confident it is "technically sound". Thank you for your positive comments about our paper, we are pleased you found it interesting. The description of the method and analysis has now been expanded upon, please see pages 6-7, lines 147-170. Abstract Q., As the authors indicate in the introduction, the term transition is often used to indicate a move between different services/types of treatment etc, as well as being used in the sense the authors mean here, more a transition between disease states/ways of living. I am wondering therefore if this could be made clearer in the title and/or abstract. For example the objective is currently: “To understand the transitions experienced by people with Parkinson’s and their family members living in the community.” However, this does not make it clear what is meant by transition – so could this be explained a little more? The abstract has been amended accordingly to clarify the use of the word ‘transition’. Q., It would also be helpful in the abstract to know which subthemes belong to which themes. Numbers have been added so that it is clearer which subtheme is associated with the theme. Please see page 2, lines 41-46. Introduction Q.,This is mainly clear – with just some queries about the final paragraph, covered below. This has been amended to clarify. Please see page 4, lines 91-92. Method Q., A little more explanation and coherence is needed regarding the method. The authors say that they conducted thematic analysis using Braun & Clarke’s (2006) approach. However, Braun & Clarke have since developed and refined their method and tend now to refer to “reflexive thematic analysis” (e.g. Braun, V. & Clarke, V. (2019) Reflecting on reflexive thematic analysis, Qualitative Research in Sport, Exercise and Health, 11:4, 589-597, DOI: 10.1080/2159676X.2019.1628806). As they outline, there are actually various types of thematic analysis so it is helpful to be more specific about which one is meant. There is a helpful summary of their development of the approach here: https://www.psych.auckland.ac.nz/en/about/thematic-analysis.html and in their new book (Braun, V. & Clarke, V. (2021). Thematic Analysis: A Practical Guide. Sage.) So I think the authors need to be more explicit whether they are using the inductive approach that Braun & Clarke outline (reflexive thematic analysis) or whether they are using a more deductive approach (e.g. codebook thematic analysis or framework analysis for example). Thank you for this and we welcomed the new publications on this from Braun and Clarke. We believe we have followed the more codebook thematic analysis approach. Although a team approach was adopted this was not for a marker of quality as would be the case in coding reliability TA, but instead to widen our discussion, ideas and interpretation of the data. We have added detail of this type of TA to the analysis section and added more detail generally about our analysis. Q., The introduction says that the “lens of transitions” (page 4) will be used to look at the “lived experience” and then later the same paragraph talks about the “framework of transitions”. It also says that “mapping Parkinson’s onto transitions” (page 4) is a new approach. How was the mapping and using of a framework/lens actually implemented in practice? At what point was the lens introduced when conducting the data analysis? What did the mapping involve? Was the “framework of transitions” taken from previous literature or constructed for the current project? There is very little about this in the method. The method states that an “inductive approach” (page 5) was used and then later that “the concept of transitions was identified and applied” – so does this mean that the concept of transitions came from the data (i.e. when doing the inductive analysis, an overarching theme of transitions was seen) or that the project was about transitions specifically and that the interview schedule and analysis was conducted specifically focusing on transitions? This needs to be a bit clearer both in the introduction and method. The process of analysis then needs more explanation with appropriate methodological references. The concept and relevance of transitions became apparent during the analysis. We have added this to the analysis section. Q., As a more minor issue- in a couple of places the language used does not quite align with the Braun & Clarke conceptualisation of the method. For example, Braun & Clarke argue strongly against using the word “emerge” for themes (as is used here on page 4: “no new themes emerged”) and similarly are critical about the concept of saturation (Braun, V. & Clarke, V. (2021) To saturate or not to saturate? Questioning data saturation as a useful concept for thematic analysis and sample-size rationales, Qualitative Research in Sport, Exercise and Health, 13:2, 201-216, DOI: 10.1080/2159676X.2019.1704846). Thus a little more is needed here (with appropriate references) to indicate how “saturation” was conceptualised and utilised. We completely agree with the reviewer and have removed notion of emerge. We also agree the notion of saturation although has merits we feel is difficult, we were aware of the idea of information power when conducting our study and recruitment and were guided by the fact this was an explorative study, considered the quality and richness of our interviews, and have referred to this in our methods section (see page 4, lines 103-108). Towards the end of our data collection, we were aware as a team that the interviews were sufficient to answer our aims and objectives. Q., Page 11: The topic guide was developed with reference to “the study objectives and literature” – could the citations of the relevant literature be included? Some relevant references have now been added, however the citations are too wide to include all that would have informed our topic guide. Q., Pages 11-12: “The separate code lists were compared and reviewed to create an initial coding frame. The coding frame was discussed with other members of the team (anon), who read a proportion of the transcripts. The agreed coding frame was then applied to the remaining interviews”. How many transcripts were looked at first to form the initial coding frame? The description in the analysis section (pages 6-7) has now been expanded upon to include such information. Results Q., The three themes and subthemes seem coherent and informative and the thematic map (Figure 1) gives a helpful overview of the findings. A perhaps minor point, but the quotations largely seem to focus on each phase (i.e. be static), rather than talk about the transition from one phase to the next, which is the focus, I think, of the current work? Is there anything that can be done in each theme to bring the nature of the transition (from one phase to the next) more to the fore, if this indeed is part of the intended focus? Or is each theme/phase itself seen as a transition? Perhaps this could this be clearer. A clarifying sentence has been added, (see page 20 line 494) that each theme/phase is seen as a transition. Discussion Q., There is a considerable body of (arguably) similar work in Parkinson’s that I think needs some consideration in the discussion. The Soundy et al. (2014) review is already included but there are also two more recent reviews, which I think could be relevant, both as a whole and the papers cited within: Rutten S, van den Heuvel OA, de Kruif A, et al. The subjective experience of living with Parkinson’s disease: a meta-ethnography of qualitative literature. J Parkinsons Dis.2021;11(1):139–151 and Wieringa G, Dale M, Eccles FJR. Adjusting to living with Parkinson's disease; a meta-ethnography of qualitative research. Disabil Rehabil. 2021:1-20. doi: 10.1080/09638288.2021.1981467. Epub ahead of print. The Rutten et al. review is particularly relevant to the current paper as it discusses the changes over time. The following paper also perhaps has findings relevant to the current work: Vann-Ward T, Morse JM, Charmaz K. Preserving Self: Theorizing the Social and Psychological Processes of Living With Parkinson Disease. Qualitative Health Research. 2017;27(7):964-982. doi:10.1177/1049732317707494) Thank you for these very helpful references, which have been included in the reworked discussion. Q., Page 19: “Parkinson’s affects all areas of life and acceptance has to be reframed over time (20) reflecting the ongoing transitions described in our findings.” Can this sentence be explained a little more?” Acceptance is only mentioned explicitly once in the results (as far as I can see) so it is not clear at the moment how the acceptance changing over time plays out in the results of the current paper. I think either this needs making more explicit throughout the results, or the way in which acceptance changes throughout the transitions needs to be explained more here in the discussion. The wording has been changed (page 20, lines 497-498) in order to add explanation to this point. Page 19: “Whilst some of the challenges of having Parkinson’s have been reported elsewhere (12, 22-24) to our knowledge this is the first study to map them onto these various transitions across the Parkinson’s.” Again, linking to my comment above on the method – was the aim therefore to “map” difficulties onto the different phases of Parkinson’s? The concept and relevance of transitions became apparent during the analysis, which has been clarified in the methods section and discussion. Q., One paragraph on page 19 focuses on the diagnosis phase. Several previous papers have also similarly considered the effects of receiving a diagnosis and could be cited including: Phillips, L.J. (2006). Dropping the bomb: The experience of being diagnosed with Parkinson’s disease. Geriatric Nursing, 27, 362-369. doi: 10.1016/j.gerinurse.2006.10.012 Pinder. (1992). Coherence and incoherence: doctors’ and patients’ perspectives on the diagnosis of Parkinson’s disease. Sociology of Health and Illness, 13, 1-23. doi: 10.1111/j.14679566.1992.tb00111.x and Warren, E., Eccles, F., Travers, V., & Simpson, J. (2016). The experiences of being diagnosed with Parkinson’s disease. British Journal of Neuroscience Nursing, 12, 288-296. doi: 10.12968/bjnn.2016.12.6.288. The following review includes Parkinson’s and so also may be relevant: Anestis E, Eccles F, Fletcher I, French M, Simpson J. Giving and receiving a diagnosis of a progressive neurological condition: A scoping review of doctors' and patients' perspectives. Patient Educ Couns. 2020; 103(9):1709-1723. doi: 10.1016/j.pec.2020.03.023. Epub ahead of print. Thank you for these references, this is very helpful. In response to reviewer 1’s comments, we have expanded this section, including using these publications suggested above. Q., Page 19: “The impact of the way in which a diagnosis is delivered resounded across the disease course and there is learning from other long-term conditions (LTC), such as dementia, where there are aspirations to ‘diagnose well’ to mitigate the impact of diagnosis delivery.” I think there should be a citation after this statement. We have now added a reference. Q., Finally, the following study may be a useful comparator? Bogosian, A.,, Morgan, M., Bishop, F. L., Day, F., & Moss-Morris, R. (2017). Adjustment modes in the trajectory of progressive multiple sclerosis: a qualitative study and conceptual model. Psychology & Health, 32(3), 343–360. https://doi-org.ezproxy.lancs.ac.uk/10.1080/08870446.2016.1268691 Whilst a useful paper to be aware of we have not included reference to this paper because, as suggested by reviewer 1, people with MS may be affected at a younger average age and therefore report different experiences. Submitted filename: Reviewer responses_11-03-22.docx Click here for additional data file. 8 Apr 2022
PONE-D-21-37562R1
Transitions and challenges for people with Parkinson’s and their family members: A qualitative study
PLOS ONE Dear Dr. Davies, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit, and the reviewers have pointed out that the manuscript is substantially improved but there remain a few minor issues that require some further attention.  I agree that the revised manuscript is markedly improved and believe the points flagged below should be straightforward to address. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process,
Please submit your revised manuscript by May 23 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Sander L. Hitzig Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a dramatically improved manuscript. I have only minor remaining comments. Figure 1 – The upwards arrows still go beyond the gradually downtrending progression line. Should they just go up to the line? Also, people with PD generally decline after “acute episodes” (sometimes then improving again, but often not back to their prior baseline). The figure might be more helpful if it captures this common response in PD to episodes like acute illness or hospitalization. This common experience is also reflected in the quotes (line 380, for example) so it would be good if the figure reflected this, as well. Minor – Line 506, missing “w” in “was” The discussion is markedly improved. Minor – The sentence of the first paragraph on page 36 of the full PDF (lines 546-550) is difficult to follow. Please break into two sentences and reword for clarity. Minor – Box 1: There is an empty box under the first subtheme. With regard to data availabililty, I defer to PLoS One. I agree with the authors that typically transcripts are not submitted for reasons of confidentiality. Sometimes the code book with all relevant quotes is submitted, though. Reviewer #2: I think the authors have done an excellent job in responding to the reviewers’ comments. In particular, the description of the method is clear and now feels in line with what was carried out and the discussion feels much more thorough with more extensive references to the wider literature. I have only these very minor comments remaining: Page 7 (line 169) “lens transitions” I think there is word missing Page 25 (line 645) “Those with Parkinson’s, and those closest to them, reframe acceptance over the trajectory of the condition” I am wondering if this could be slightly rephrased. As acceptance has not really been covered in the discussion, it seems odd to have it here as the first statement of the conclusion. Page 26 (Box 1) There is nothing in the strategies box for the subtheme “navigating reactions?” Is something missing from here? Figure: Thank you for providing the legend which now gives a clear explanation. I’m not sure the thin blue wiggly line adds anything for me (seems to obscure part of the text on my version) but perhaps this looks clearer on other versions. Looking at the blue arrows pointing upwards from the acute episodes box – the final one seems thinner – is that intended (or again, might just be how the formatting turns out on my screen). ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
27 Apr 2022 Thank you for your positive review of the manuscript ‘Transitions and challenges for people with Parkinson’s and their family members: A qualitative study’ and for drawing our attention to the minor points raised. A marked-up copy of the manuscript addressing the final minor amendments has been uploaded, and are set out below. We have also uploaded a clean version of the manuscript. Reviewer #1: 1., Figure 1 – The upwards arrows still go beyond the gradually downtrending progression line. Should they just go up to the line? Also, people with PD generally decline after “acute episodes” (sometimes then improving again, but often not back to their prior baseline). The figure might be more helpful if it captures this common response in PD to episodes like acute illness or hospitalization. This common experience is also reflected in the quotes (line 380, for example) so it would be good if the figure reflected this, as well. The upward arrows have been changed as suggested and the reflection of acute episodes and not returning back to prior baseline. 2., Minor – Line 506, missing “w” in “was” Line 506 reads “The first point of transition was identified as when participants were told they have a chronic” which is therefore correct. 3., Minor – The sentence of the first paragraph on page 36 of the full PDF (lines 546-550) is difficult to follow. Please break into two sentences and reword for clarity. This sentence has been broken down and reworded as suggested. 4., Minor – Box 1: There is an empty box under the first subtheme. This error has been corrected. 5., With regard to data availabililty, I defer to PLoS One. I agree with the authors that typically transcripts are not submitted for reasons of confidentiality. Sometimes the code book with all relevant quotes is submitted, though. All relevant data is included in the manuscript itself with quotes from participants. Reviewer #2: 6., Page 7 (line 169) “lens transitions” I think there is word missing Thank you for noticing this, the missing word ‘of’ has now been added. 7., Page 25 (line 645) “Those with Parkinson’s, and those closest to them, reframe acceptance over the trajectory of the condition” I am wondering if this could be slightly rephrased. As acceptance has not really been covered in the discussion, it seems odd to have it here as the first statement of the conclusion. This has now been reworded to closely reflect the content of the discussion. 8., Page 26 (Box 1) There is nothing in the strategies box for the subtheme “navigating reactions?” Is something missing from here? The strategies in box 1 apply to both sub-themes which is now clearer following the removal of the erroneous blank row 9., Figure: Thank you for providing the legend which now gives a clear explanation. I’m not sure the thin blue wiggly line adds anything for me (seems to obscure part of the text on my version) but perhaps this looks clearer on other versions. Looking at the blue arrows pointing upwards from the acute episodes box – the final one seems thinner – is that intended (or again, might just be how the formatting turns out on my screen). As addressed for reviewer 1, the figure has been amended and the line now reflects more clearly the declines that take place after acute episodes, for example. The arrows are now the same width to one another this may be a formatting issue. 3 May 2022 Transitions and challenges for people with Parkinson’s and their family members: A qualitative study PONE-D-21-37562R2 Dear Dr. Davies, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Sander L. Hitzig Academic Editor PLOS ONE 12 May 2022 PONE-D-21-37562R2 Transitions and challenges for people with Parkinson’s and their family members: A qualitative study Dear Dr. Davies: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Sander L. Hitzig Academic Editor PLOS ONE
Implications informed by the over-arching concept of transitions:
 ➢ The concept of transitions could act as a map to identify times of significant adaption and change, of what is important to the individual, and which support may be needed
 ➢ Transitions could be used to encourage and engage in discussions acting as a prompt/guide
Implications informed by themes and sub-themes
Theme: Being told you are a person with Parkinson’s (early phase):
Sub-themePotential strategies to address challenges identified in sub-theme
Receiving and accepting a diagnosis; Navigating reactions ➢ Pre- and post-diagnostic care could include clear, empathetic explanations of the diagnostic process
 ➢ Consider facilitation of meeting with others at the same age and stage, i.e., signposting to a young-onset PD support group or diagnosis specific group
Theme: Living with Parkinson’s (mid phase)
Sub-themePotential strategies to address challenges identified in sub-theme
Changing social interactions and maintaining sense of self ➢ Ongoing adaptive facilitation by health professionals to help those with Parkinson’s and family members maintain and promote social engagement for example coaching to improve self-efficacy and manage changes in social roles
 ➢ Individuals and health professionals should focus on assets, such as abilities, strengths, existing support networks and meaningful activities rather than responding to functional deficits alone
 ➢ Facilitate enabling individuals to recognise their needs, make informed choices, and prepare for the incorporation of future changes that will be increasingly demanded by Parkinson’s
Information: wanting to know but not wanting to know ➢ Bespoke, tailored information for those with Parkinson’s and family members
 ➢ Facilitating collaborative approaches between family members in preparation for when discussion about long-term future and end of life care is needed
Finding a place in the healthcare system ➢ Promote awareness of such campaigns such as Parkinson’s UK ‘Get it on time’ [64] that works to ensure needs are met within the healthcare system
 ➢ Support with navigating the healthcare system
 ➢ Training of non-specialist Healthcare Professionals about Parkinson’s
 ➢ Improved continuity in care
Theme: Increasing dependency (decline phase).
Sub-themePotential strategies to address challenges identified in sub-theme
Changes in roles and relationships ➢ Individual and ongoing support for spouses and family carers
Becoming increasingly dependent ➢ Important to increasingly involve those with Parkinson’s and families in all consultations and decisions about delivery of care, to acknowledge their experiences and facilitate collaborative communication and working between family members
 ➢ Agility of healthcare professionals to respond to changes in order to offer appropriate, timely support for areas of life that are important to the individual
  52 in total

1.  Sample Size in Qualitative Interview Studies: Guided by Information Power.

Authors:  Kirsti Malterud; Volkert Dirk Siersma; Ann Dorrit Guassora
Journal:  Qual Health Res       Date:  2016-07-10

2.  The role and profile of the informal carer in meeting the needs of people with advancing Parkinson's disease.

Authors:  Annette Hand; Lloyd Louis Oates; William Keith Gray; Richard W Walker
Journal:  Aging Ment Health       Date:  2018-01-02       Impact factor: 3.658

3.  Improving self-management for persons with Parkinson's disease through education focusing on management of daily life: Patients' and relatives' experience of the Swedish National Parkinson School.

Authors:  Carina Hellqvist; Nil Dizdar; Peter Hagell; Carina Berterö; Märta Sund-Levander
Journal:  J Clin Nurs       Date:  2018-07-30       Impact factor: 3.036

Review 4.  Unmet needs in Parkinson's disease: New horizons in a changing landscape.

Authors:  K Ray Chaudhuri; Roongroj Bhidayasiri; Teus van Laar
Journal:  Parkinsonism Relat Disord       Date:  2016-12-06       Impact factor: 4.891

5.  Factors associated with life satisfaction in Parkinson's disease.

Authors:  K Rosqvist; P Hagell; P Odin; H Ekström; S Iwarsson; M H Nilsson
Journal:  Acta Neurol Scand       Date:  2016-10-10       Impact factor: 3.209

6.  The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: a simple grading system.

Authors:  K Ray Chaudhuri; A Sauerbier; J M Rojo; K Sethi; A H V Schapira; R G Brown; A Antonini; F Stocchi; P Odin; K Bhattacharya; Y Tsuboi; K Abe; A Rizos; Carmen Rodriguez-Blazquez; P Martinez-Martin
Journal:  Parkinsonism Relat Disord       Date:  2015-01-05       Impact factor: 4.891

7.  Adjusting to living with Parkinson's disease; a meta-ethnography of qualitative research.

Authors:  Gina Wieringa; Maria Dale; Fiona J R Eccles
Journal:  Disabil Rehabil       Date:  2021-09-30       Impact factor: 3.033

Review 8.  Giving and receiving a diagnosis of a progressive neurological condition: A scoping review of doctors' and patients' perspectives.

Authors:  Eleftherios Anestis; Fiona Eccles; Ian Fletcher; Maddy French; Jane Simpson
Journal:  Patient Educ Couns       Date:  2020-04-02

9.  Activities of daily living, depression, and quality of life in Parkinson's disease.

Authors:  Blake J Lawrence; Natalie Gasson; Robert Kane; Romola S Bucks; Andrea M Loftus
Journal:  PLoS One       Date:  2014-07-15       Impact factor: 3.240

Review 10.  Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.

Authors:  Matej Skorvanek; Jennifer G Goldman; Marjan Jahanshahi; Connie Marras; Irena Rektorova; Ben Schmand; Erik van Duijn; Christopher G Goetz; Daniel Weintraub; Glenn T Stebbins; Pablo Martinez-Martin
Journal:  Mov Disord       Date:  2017-11-23       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.